Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.28% | 60.92 | 0.0% | $915.58m | |
| NVAX | Novavax, Inc. | 2.19% | 106.85 | 102.0% | $843.89m | |
| AMGN | Amgen, Inc. | -1.21% | 253.15 | 1.3% | $733.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.13% | 654.50 | 2.5% | $702.41m | |
| GILD | Gilead Sciences, Inc. | -0.13% | 76.32 | 1.0% | $675.67m | |
| BIIB | Biogen, Inc. | -0.54% | 268.35 | 1.6% | $573.84m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.31% | 300.00 | 1.9% | $524.61m | |
| ILMN | Illumina, Inc. | -1.92% | 372.12 | 3.5% | $297.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.98% | 112.46 | 2.0% | $230.21m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.16% | 127.77 | 4.3% | $212.31m | |
| SGEN | Seattle Genetics, Inc. | 3.34% | 176.14 | 6.1% | $207.80m | |
| SRNE | Sorrento Therapeutics, Inc. | 0.27% | 7.40 | 1.8% | $195.70m | |
| IMMU | Immunomedics, Inc. | 1.30% | 41.16 | 11.0% | $178.10m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.25% | 163.89 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 0.80% | 108.65 | 2.5% | $166.01m |
Company Profile
BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.